Peregrine Capital Management LLC Amicus Therapeutics, Inc. Call Options Transaction History
Peregrine Capital Management LLC
- $3.09 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding FOLD
# of Institutions
307Shares Held
332MCall Options Held
396KPut Options Held
249K-
Vanguard Group Inc Valley Forge, PA29.4MShares$261 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$258 Million0.03% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$216 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY18MShares$159 Million1.88% of portfolio
-
William Blair Investment Management, LLC Chicago, IL14.6MShares$130 Million0.24% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.49B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...